文献速递运动医学小儿骨科

青少年运动员脑震荡后持续性脑震荡后症状临床预测工具的多中心样本效用:儿科运动脑震荡结局(SCOPE)研究

Utility of a Clinical Prediction Tool for Persisting Postconcussive Symptoms in a Multicenter Sample of Youth Athletes With Concussion: The Sport Concussion Outcomes in Pediatrics (SCOPE) Study.
PubMed 文献 · Am J Sports Med · 2023-10-04

该多中心队列研究纳入184例8-18岁脑震荡后14天内就诊的儿科及青少年患者,评估5P临床风险评分对持续性脑震荡后症状(PPCS)的预测效用。结果显示,调整初始症状严重度、评估时间及评估场所后,较高的初始5P风险评分与发生PPCS的 odds 显著增加相关(调整OR 1.49,95%CI 1.07-2.08,P=0.019),且与症状缓解时间延长显著相关(HR 0.80,95%CI 0.74-0.88,P<0.001)。

要点

  • 5P风险评分在脑震荡后14天内获取,可预测青少年运动员发生PPCS的风险。
  • PPCS组初始5P平均风险评分7.9±1.7,高于无PPCS组的5.9±2.3(P<0.001)。
  • 调整后,5P评分每增加1分,PPCS发生 odds 增加49%(调整OR 1.49,95%CI 1.07-2.08)。

核心结论

  • 在多中心青少年运动员样本中,5P风险评分能准确预测哪些运动员可能处于发生PPCS的风险中。

研究设计与样本

  • 多中心队列研究,证据等级2级。
  • 纳入来自7个儿科医学中心和6个中学运动训练设施的8-18岁脑震荡患者,伤后≤14天入组,随访至症状缓解。
  • 初始就诊时(脑震荡后平均4.9±2.9天)获取5P临床风险评分和脑震荡后症状量表总分症状严重度。
  • 根据症状缓解时间分组:PPCS组(症状缓解≥28天)和无PPCS组(<28天)。
  • 采用二元逻辑回归模型评估基于5P风险评分的PPCS发生 odds,采用Cox比例风险模型评估5P评分对总症状缓解时间的预测效用。

主要发现

  • 共184例参与者入组并随访至症状缓解(平均年龄15.2±2.1岁;35%为女性)。
  • 全样本平均症状缓解时间为17.6±3.7天;16%(n=30)的参与者发生PPCS。
  • PPCS组初始5P风险评分平均为7.9±1.7,无PPCS组为5.9±2.3,组间差异显著(P<0.001)。
  • 调整初始症状严重度、评估时间和评估场所后,较高的初始5P风险评分与发生PPCS的 odds 显著增加相关(调整OR 1.49;95%CI 1.07-2.08;P=0.019)。
  • 较高的5P风险评分与总症状缓解时间延长显著相关(HR 0.80;95%CI 0.74-0.88;P<0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A validated clinical risk tool has been developed to identify pediatric and adolescent patients at risk of developing persisting symptoms after concussion, but has not been prospectively investigated within a sample of athletes seen after concussion by primary care sports medicine physicians and/or athletic trainers. PURPOSE: To determine whether a validated clinical risk prediction tool for persistent postconcussive symptoms (PPCSs) predicted which patients would develop PPCSs when obtained within 14 days of concussion among a multicenter sample of adolescent athletes. STUDY DESIGN: Cohort study; Level of evidence, 2. METHODS: Pediatric and adolescent patients (8-18 years of age) from 7 pediatric medical centers and 6 secondary school athletic training facilities who were diagnosed with a concussion and presented ≤14 days after concussion were enrolled as part of the Sport Concussion Outcomes in Pediatrics (SCOPE) study during their initial visit and were followed until symptom resolution. Clinical risk scores (Predicting and Preventing Post-concussive Problems in Pediatrics [5P]) and total symptom severity were obtained using the Post-Concussion Symptom Inventory at the initial visit (mean, 4.9 ± 2.9 days after concussion). Participants were then compared based on symptom resolution time: PPCS group (≥28 days to symptom resolution) and no-PPCS group (<28 days). The authors assessed the odds of developing PPCSs based on the 5P risk score using a binary logistic regression model and the utility of the clinical risk prediction tool to identify total time to symptom resolution using a Cox proportional hazards model. RESULTS: A total of 184 participants enrolled, underwent initial evaluation, and were followed until symptom resolution (mean age, 15.2 ± 2.1 years; 35% female). The mean time to symptom resolution across the entire sample was 17.6 ± 3.7 days; 16% (n = 30) of participants developed PPCS. Those in the PPCS group had significantly greater mean initial total 5P risk scores than those in the no-PPCS group (7.9 ± 1.7 vs 5.9 ± 2.3, respectively; P < .001). After adjustment for initial symptom severity, time to assessment, and assessment setting, a higher initial total 5P risk score was associated with a significantly greater odds of developing PPCSs (adjusted odds ratio, 1.49; 95% CI, 1.07-2.08; P = .019). Furthermore, a higher 5P risk score was significantly associated with longer total symptom resolution time (hazard ratio, 0.80; 95% CI, 0.74-0.88; P < .001). CONCLUSION: In a multicenter sample of youth athletes seen in different outpatient health care settings, the 5P risk score accurately predicted which athletes may be at risk for developing PPCSs.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Miller SM, Valovich McLeod TC, Zaslow TL, et al. Utility of a Clinical Prediction Tool for Persisting Postconcussive Symptoms in a Multicenter Sample of Youth Athletes With Concussion: The Sport Concussion Outcomes in Pediatrics (SCOPE) Study. Am J Sports Med. 2023. PMID: 37794642. doi:10.1177/03635465231201610

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。